Notice Regarding a Merger of Wholly-owned Subsidiaries

For more information, please click the button below. (PDF)

カテゴリー: M&A/partnership

other

Notice Regarding Contract on Distribution Operation of Dovonex®Ointment50μg/g, a Topical Treatment of Psoriasis Vulgaris by LEO Pharma K.K.

2022.10.25

M&A/partnership

Notice Regarding Change of the Merger Date of Wholly-owned Subsidiaries

2023.01.23

PAGE TOP

[data-arkb-linkbox]{cursor:auto}[data-arkb-link][aria-hidden="true"]{visibility:visible;color:transparent;z-index:0;width:100%;height:100%;pointer-events:auto}a.arkb-boxLink__title{text-decoration:underline}

News Release

Notice Regarding Contract on Distribution Operation of Dovonex®Ointment50μg/g, a Topical Treatment of Psoriasis Vulgaris by LEO Pharma K.K.

Notice Regarding Change of the Merger Date of Wholly-owned Subsidiaries